Belgium· BE-AMP-SAM597333-00

Kerendia 20 mg

A finerenone product containing finerenone, registered in Belgium by Bayer. The same ATC class is registered in 15 of our 19 countries.

ATC C03DA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKerendia 20 mgATCC03DA05REGISTER NO.BE-AMP-SAM597333-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Finerenone is registered in 15 of 19 countries.

Countries holding a registration under ATC C03DA05 (finerenone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Finerenone · ATC C03DA05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of finerenone costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Finerenone · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$5.64
  • CH Switzerland$4.82
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Finerenone
Manufacturer
Bayer
Country
Belgium (BE)
ATC code
C03DA05
ATC class
Finerenone
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    4512125
    EUR 72.14
  • be_apb
    4512117
    EUR 225.81
  • be_apb
    4512141
  • be_apb
    7737042

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Finerenone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All finerenone products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kerendia
  • Liechtenstein · Kerendia
  • Norway · Kerendia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/58258cd5-3292-40ee-966f-4e1ceaf71ab0
GET /v1/drugs/58258cd5-3292-40ee-966f-4e1ceaf71ab0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kerendia 20 mg",
  "name_fr": "Kerendia 20 mg",
  "name_nl": "Kerendia 20 mg",
  "amp_code": "SAM597333-00",
  "strengths": [
    "20.0000",
    "40.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Finerenone",
    "Lactose",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Finerenone",
  "authorisation_numbers": [
    "EU/1/21/1616/006",
    "EU/1/21/1616/009",
    "EU/1/21/1616/010",
    "EU/1/21/1616/007",
    "EU/1/21/1616/008"
  ]
}

See everything about finerenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.